Clinical Trials · NCT07783854
A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Enrollment
- 72
- Start date
- Sep 2026
- Locations
- See registry
- Primary endpoint
- Percentage change in body weight from baseline to week 24